Can Low Molecular Weight Heparins Circumvent the Problem of Coumadine and Chemotherapy Interaction in Cancer Patients with Prosthetic Heart Valves?

Simple item page
dc.contributor.authorSezer, Ahmet
dc.contributor.authorSumbul, Ahmet Taner
dc.contributor.authorAbali, Gulcan
dc.contributor.authorSumbul, Zehra
dc.contributor.authorMuallaoglu, Sadik
dc.contributor.authorAbali, Huseyin
dc.date.accessioned2023-02-21T12:35:00Z
dc.date.available2023-02-21T12:35:00Z
dc.date.issued2014-01-01
dc.description.issue4
dc.description.pages1889-1890
dc.description.volume15
dc.identifier.doi10.7314/APJCP.2014.15.4.1889
dc.identifier.urihttps://hdl.handle.net/11443/1852
dc.identifier.urihttp://dx.doi.org/10.7314/APJCP.2014.15.4.1889
dc.identifier.wosWOS:000333670100069
dc.publisherASIAN PACIFIC ORGANIZATION CANCER PREVENTION
dc.relation.ispartofASIAN PACIFIC JOURNAL OF CANCER PREVENTION
dc.titleCan Low Molecular Weight Heparins Circumvent the Problem of Coumadine and Chemotherapy Interaction in Cancer Patients with Prosthetic Heart Valves?
dc.typeArticle

Files

Collections

WOS